Standout Papers

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple scler... 1995 2026 2005 2015 1.5k
  1. Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis (1995)
    K. P. Johnson, Benjamin Brooks et al. Neurology

Immediate Impact

1 by Nobel laureates 17 from Science/Nature 109 standout
Sub-graph 1 of 15

Citing Papers

Trends in peptide drug discovery
2021 Standout
A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis
2021 StandoutNature
4 intermediate papers

Works of J. S. Wolinsky being referenced

The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics
2012
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
1995 Standout
and 4 more

Author Peers

Author Last Decade Papers Cites
J. S. Wolinsky 2756 603 1324 912 37 3.3k
Mark S. Freedman 2825 620 1324 915 44 3.4k
K. P. Johnson 2434 642 1165 795 40 3.6k
Daniel Wynn 2642 990 1117 641 49 3.5k
J. A. Cohen 2413 522 1132 782 23 2.9k
Jeffrey Cohen 2387 764 914 705 51 2.9k
Vesna Brinar 2567 589 1170 768 90 3.3k
Gavin Giovannoni 2955 1194 1049 801 62 3.6k
J. Baskerville 3234 593 1333 1163 43 4.4k
Lawrence W. Myers 3823 806 1506 1003 66 5.2k
Mads Ravnborg 2132 576 1159 574 59 3.0k

All Works

Loading papers...

Rankless by CCL
2026